Bioinformatics brings to light new combinations of drugs to fight breast cancer


Combined therapy using two drugs emerges as a promising approach to tackle cancer resistance. Biocomputational analyses at IRB help to detect new synergistic combinations, such as raloxifene and cabozantinib, for the treatment of breast cancer.



from Biotech News